Gliquidone
Chemical compound / From Wikipedia, the free encyclopedia
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class.[1] It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Glurenorm |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Oral (tablets) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | High (Tmax = 2–3 hours) |
Metabolism | Extensive hepatic |
Onset of action | 1–1.5 hours |
Excretion | Biliary (95%), renal (5%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.046.770 |
Chemical and physical data | |
Formula | C27H33N3O6S |
Molar mass | 527.64 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close